Insights

Stay up to date on PsychoGenics’ latest research, press releases, and industry developments in preclinical drug discovery. Combine our expertise with yours to spark the translational power of your next CNS breakthrough.

POSTER

Functional, Sensorimotor, and Cognitive Outcomes Following Unilateral MCAO in Rats

June 24, 2026
Read More
POSTER

Behavioral and pharmacological characterization of the isosorbide dinitrate model of headache in male and female rats

June 15, 2026
Read More
RESEARCH UPDATES

Characterization of a Mouse Model of Fragile X Syndrome

January 28, 2025
Read More
POSTER

Model Development of a T8 Rat Contusion Model: Different Lesion Severities Elicited Distinct Locomotor and Sensory Profiles.

November 19, 2024
Read More
POSTER

In vivo PK, side effect profile, and efficacy of multiple clinically used compounds in female and male rats

October 15, 2024
Read More
POSTER

Phenotyping of the TDP-43 ΔNLS mouse model of ALS

October 15, 2024
Read More
POSTER

Standardized Locomotor and Sensory behavior changes in a graded contusive spinal cord injury model

October 15, 2024
Read More
POSTER

Characterization of a SOD1 Rat Model of ALS: Behavior and Electrophysiology

October 15, 2024
Read More
POSTER

Evaluation of the abuse liability of gabapentin and duloxetine in male and female rats using two approaches: intravenous self-administration and conditioned place preference

October 15, 2024
Read More
POSTER

Comparison of rat models of vascular headache and trigeminal sensitization in male and female rats.

October 15, 2024
Read More
PUBLICATION

A systematic assessment of robustness in CNS safety pharmacology

October 10, 2024
Read More